MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
VolitionRx Limited Depreciation & Amortization 2011-2026 | VNRX
Annual Depreciation & Amortization VolitionRx Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 984 K | 1.11 M | 1.15 M | 936 K | 945 K | 716 K | 677 K | 636 K | 528 K | 309 K | 236 K | 142 K | 146 K | 136 K | 119 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.15 M | 119 K | 585 K |
Quarterly Depreciation & Amortization VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 252 K | - | - | - | 263 K | - | - | - | 272 K | - | 687 K | 450 K | 224 K | - | 709 K | 472 K | 227 K | - | 525 K | 359 K | 180 K | - | 510 K | 339 K | 168 K | - | 475 K | 318 K | 156 K | - | 371 K | 226 K | 93.3 K | - | 231 K | 152 K | 72.2 K | - | 164 K | 91.5 K | 40.2 K | - | 99.9 K | 63.6 K | 30.9 K | - | 109 K | 72.5 K | 36.4 K | - | 103 K | 69.8 K | 33 K | - | 77.6 K | 47.6 K | 23.9 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 709 K | 23.9 K | 226 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 16.65 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
321 M | $ 113.98 | -0.78 % | $ 34.6 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 24.15 | -2.23 % | $ 671 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.61 | -1.21 % | $ 2.14 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 22.01 | 0.43 % | $ 1.17 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 15.24 | -0.39 % | $ 461 M | USA |
 |
Illumina
ILMN
|
354 M | $ 125.07 | -1.46 % | $ 19.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Charles River Laboratories International
CRL
|
403 M | $ 167.08 | 0.22 % | $ 8.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 82.63 | -0.59 % | $ 10.4 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 82.9 | -0.78 % | $ 5.59 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.93 | - | $ 8.54 M | USA |
 |
Personalis
PSNL
|
10.9 M | $ 5.34 | -2.92 % | $ 316 M | USA |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 7.03 | -2.09 % | $ 293 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 403.62 | -1.5 % | $ 11.6 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.18 | -0.46 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 111.86 | 9.14 % | $ 9.23 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 260.29 | 0.29 % | $ 21.7 B | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 9.6 | 6.43 % | $ 1.23 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 57.42 | -2.92 % | $ 3.43 B | USA |
 |
Celcuity
CELC
|
167 K | $ 118.83 | -1.04 % | $ 5.56 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.19 | -1.61 % | $ 1.99 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 15.88 | -5.7 % | $ 355 M | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.77 | -1.45 % | $ 442 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 196.02 | -2.08 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 192.19 | -1.43 % | $ 21.3 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
Exagen
XGN
|
2.1 M | $ 2.68 | -1.83 % | $ 57.8 M | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |